To monitor weight regain after therapy discontinuation in patients with migraine experiencing weight loss during topiramate (TPM) treatment
the probability of relapse after discontinuation of migraine preventive treatment with topiramat
OBJECTIVE: The objective of this study was to determine the efficacy and tolerability of long-term t...
Abstract The majority of patients with migraine headaches are treated in non-specialized institution...
To monitor weight regain after therapy discontinuation in patients with migraine experiencing weight...
Background & aims: Topiramate administration is effective in preventing migraine episodes, and induc...
OBJECTIVE: To examine the safety and efficacy of topiramate (TPM) for maintaining weight following a...
INTRODUCTION: Demographic and clinical variables were examined in a post hoc analysis of the PROlong...
This paper reviews the clinical implications of topiramate (TPM)-induced cognitive deficits in patie...
The effects of discontinuing topiramate after a treatment period of 6 months in 818 patients with mi...
Background Use of preventive therapy for migraine is often recommended for only 6-9 months, but no r...
OBJECTIVE: To investigate the safety, tolerability and efficacy of combination phentermine and topir...
We reviewed the electronic records of 74 migraine patients treated with topiramate for more than 6 w...
Topiramate, FDA approved for migraine prophylaxis, is a promising treatment in IIH because it can re...
BACKGROUND: Weight loss can occur during topiramate (TPM) treatment and it should be evaluated by c...
Background: Weight gain following initiation of antiretroviral therapy (ART) is well described, part...
the probability of relapse after discontinuation of migraine preventive treatment with topiramat
OBJECTIVE: The objective of this study was to determine the efficacy and tolerability of long-term t...
Abstract The majority of patients with migraine headaches are treated in non-specialized institution...
To monitor weight regain after therapy discontinuation in patients with migraine experiencing weight...
Background & aims: Topiramate administration is effective in preventing migraine episodes, and induc...
OBJECTIVE: To examine the safety and efficacy of topiramate (TPM) for maintaining weight following a...
INTRODUCTION: Demographic and clinical variables were examined in a post hoc analysis of the PROlong...
This paper reviews the clinical implications of topiramate (TPM)-induced cognitive deficits in patie...
The effects of discontinuing topiramate after a treatment period of 6 months in 818 patients with mi...
Background Use of preventive therapy for migraine is often recommended for only 6-9 months, but no r...
OBJECTIVE: To investigate the safety, tolerability and efficacy of combination phentermine and topir...
We reviewed the electronic records of 74 migraine patients treated with topiramate for more than 6 w...
Topiramate, FDA approved for migraine prophylaxis, is a promising treatment in IIH because it can re...
BACKGROUND: Weight loss can occur during topiramate (TPM) treatment and it should be evaluated by c...
Background: Weight gain following initiation of antiretroviral therapy (ART) is well described, part...
the probability of relapse after discontinuation of migraine preventive treatment with topiramat
OBJECTIVE: The objective of this study was to determine the efficacy and tolerability of long-term t...
Abstract The majority of patients with migraine headaches are treated in non-specialized institution...
DOI
Add to ORKG